146 related articles for article (PubMed ID: 16832956)
1. No way to save a life: allowing terminally ill patients access to drugs that have not completed clinical trials is a dangerous move.
Moss RW
New Sci; 2006 Jun 3-9; 190(2554):21. PubMed ID: 16832956
[No Abstract] [Full Text] [Related]
2. Risk versus risk: decision-making dilemmas of drug regulation in the United States and Germany.
Daemmrich A; Krucken G
Sci Cult (Lond); 2000 Dec; 9(4):505-34. PubMed ID: 15988846
[No Abstract] [Full Text] [Related]
3. The Food and Drug Administration's early access and fast-track approval initiatives: how have they worked?
Shulman SR; Brown JS
Food Drug Law J; 1995; 50(4):503-31. PubMed ID: 10343017
[No Abstract] [Full Text] [Related]
4. The FDA's drug review process: ensuring drugs are safe and effective.
Meadows M
FDA Consum; 2002; 36(4):19-24. PubMed ID: 12184298
[No Abstract] [Full Text] [Related]
5. Expanded clinical trials of treatments for multiple sclerosis: copolymer 1 (COP-1) treatment investigational new drug (IND) program.
Stark Y
Ann Neurol; 1994 Jul; 36(1):114-5. PubMed ID: 8024251
[No Abstract] [Full Text] [Related]
6. Executive summary from the final reports of the National Committee to Review Current Procedures for Approval of New Drugs for Cancer and AIDS.
Oncology (Williston Park); 1991 Apr; 5(4):16, 18-9. PubMed ID: 1831034
[No Abstract] [Full Text] [Related]
7. A critical tipping point.
Zuckerman MB
US News World Rep; 2002 Apr; 132(13):72. PubMed ID: 11993366
[No Abstract] [Full Text] [Related]
8. TransMolecular receives FDA approval for 131-I-TM-601 IND application.
Expert Rev Anticancer Ther; 2002 Apr; 2(2):139. PubMed ID: 12113233
[No Abstract] [Full Text] [Related]
9. Second thoughts: do the FDA's responses to a fatal drug trial and the AIDS activist community's doubts about early access to drugs hint at a shift in basic FDA policy?
Lovell MC
Food Drug Law J; 1996; 51(2):273-94. PubMed ID: 11820202
[No Abstract] [Full Text] [Related]
10. Investigational new drug applications; amendment to clinical hold regulations for products intended for life-threatening diseases and conditions. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Jun; 65(106):34963-71. PubMed ID: 11010726
[TBL] [Abstract][Full Text] [Related]
11. Accelerated approval seen as triumph and roadblock for cancer drugs.
Susman E
J Natl Cancer Inst; 2004 Oct; 96(20):1495-6. PubMed ID: 15494596
[No Abstract] [Full Text] [Related]
12. FDA treads delicate line between safety and speed.
Oncology (Williston Park); 1999 Jan; 13(1):16. PubMed ID: 10027195
[No Abstract] [Full Text] [Related]
13. DdI approval offers second chance.
Albert SG
Am Pharm; 1991 Dec; NS31(12):6. PubMed ID: 1763779
[No Abstract] [Full Text] [Related]
14. To market, to market. The nuts and bolts of prescription drug approval.
Peterson AM
Adv Nurse Pract; 2001 Apr; 9(4):87-90. PubMed ID: 12420443
[No Abstract] [Full Text] [Related]
15. Clinical investigation of new animal drugs by veterinary practitioners.
Prater DA; Bertone JJ; Letonja T; Vaughn SD
J Am Vet Med Assoc; 1996 Jan; 208(2):190-4. PubMed ID: 8567369
[No Abstract] [Full Text] [Related]
16. New drug awaiting FDA approval may reverse bone loss.
Mayo Clin Health Lett; 2001 Nov; 19(11):4. PubMed ID: 11692627
[No Abstract] [Full Text] [Related]
17. Pregnancy and pills. New research finds prescriptions may be safer than you think.
Schultz S
US News World Rep; 1999 Apr; 126(13):64-6. PubMed ID: 10351523
[No Abstract] [Full Text] [Related]
18. FDA approves treatment IND protocol for taxol.
Clin Pharm; 1992 Nov; 11(11):912. PubMed ID: 1361164
[No Abstract] [Full Text] [Related]
19. From access to evidence: an advocate's journey.
Mayer M
J Clin Oncol; 2003 Oct; 21(20):3881-4. PubMed ID: 14551309
[No Abstract] [Full Text] [Related]
20. Expanded clinical trials of treatments for multiple sclerosis. The Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis of The National Multiple Sclerosis Society.
Whitaker JN
Ann Neurol; 1993 Dec; 34(6):755-6. PubMed ID: 8250523
[No Abstract] [Full Text] [Related]
[Next] [New Search]
